Becoming Rich with Daily Scavenging APP-Chapter 435: Artificial Blood

"To introduce our artificial blood, we first need to discuss the shortcomings of natural blood."

Zhang Yuyun knew Chen Yiyang was an outsider, so she patiently explained to him.

"Natural blood has a very significant drawback in the medical field, which is its difficulty in preservation.

Platelets in the blood can be preserved for a maximum of four days without clotting. Meanwhile, red blood cells can be preserved for up to twenty days under low temperatures.

This is why, once a severe accident occurs and hospitals are full of patients urgently needing blood transfusions, there’s a need to call for people to donate blood.

Because of preservation issues, blood banks are constantly running low. Even when there’s a large amount of blood donated at a given time, if not used promptly, it has to be destroyed due to expiration."

When Zhang Yuyun mentioned this, Chen Yiyang remembered that he had seen similar news before.

A doctor took some expired blood home to water plants, which led to public criticism.

Of course, this indeed deserves reproach. Even if the blood has expired, it was donated with good intentions and should be disposed of according to regulations, not repurposed as waste.

If the donors knew about this, they would be quite disheartened.

"So your current research on artificial blood is focused on preserving natural blood?" Chen Yiyang asked. 𝕗𝐫𝚎𝗲𝘄𝐞𝕓𝐧𝕠𝘃𝕖𝐥.𝐜𝚘𝚖

"Something like that," Zhang Yuyun continued, "We discovered that we could extract hemoglobin, the crucial component of blood, from expired blood.

Hemoglobin is the important protein responsible for transporting oxygen in red blood cells, and an essential substance needed for patients requiring blood transfusions.

We manufactured a protective membrane capable of encapsulating this hemoglobin, thereby forming stable, virus-free artificial red blood cells.

Even more importantly, these artificial red blood cells lack any blood type antigens, so there is no need to check for blood type compatibility before transfusion."

"How long can they be preserved?"

With just a few words, Zhang Yuyun made Chen Yiyang realize that this product indeed has a market, a very large one.

"At least two years, but we hope ideally it can reach five years," Zhang Yuyun directly presented a number.

From twenty days to two years.

This can’t just be described as a qualitative leap; it’s a revolutionary improvement.

"Can this artificial blood completely replace natural blood?" Chen Yiyang continued to ask.

Zhang Yuyun also very honestly replied, "The impact of such a complete replacement is very significant. Even if the clinical data is excellent, it will not be possible in the short term.

If a patient needs a part of their blood replaced to continue living, the first choice is still natural blood.

If artificial blood is used and later the patient develops complications due to various reasons, it would be difficult to absolve our artificial blood from responsibility."

"So where can it be applied?" Chen Yiyang asked.

"In emergency surgery scenarios," Zhang Yuyun replied, "For instance, in car accidents, machine injuries, or other unforeseen incidents.

Patients need to urgently receive a large infusion of blood. In the past, if the blood supply was running low, the options were either to call for emergency blood donations or face fatality.

But with my artificial blood, it can replace natural blood in such situations, temporarily preserving the patient’s life."

Zhang Yuyun finished speaking.

Chen Yiyang carefully considered this investment opportunity.

Since the investment intelligence was verified, it means Zhang Yuyun’s research is bound to succeed.

However, since it is still in the theoretical phase and lacks clinical data to support it,

Zhang Yuyun’s team conservatively estimated that it would take several more years to conduct clinical trials to ensure that this artificial blood does not have adverse effects on humans before it can be approved for market release.

Once it hits the market, the application of this technology is extensive. After all, the expiration issue of natural blood has always been severe, and expired natural blood loses its value.

By then, the expired blood can be cheaply bought to produce artificial blood for temporary use in hospitals during emergencies.

Of course, the price of this artificial blood is destined not to be too high.

After all, to some extent, natural blood is free.

The fees patients pay for blood transfusions are supposed to cover the blood center’s collection, storage, and transportation costs, along with the hospital’s matching, short-term storage, and care fees.

Therefore, there must be additional charges for artificial blood based on the original fees.

If it’s too expensive, public opinion is sure to apply pressure, tarnishing its reputation despite the good intention of benefiting the public.

As a result, the break-even pressure is actually quite significant.

Having calculated this, Chen Yiyang also somewhat understood why these small medical research companies find it hard to attract investors.

The slow payback speed and the considerable pressure to recoup investments, along with public opinion risks, deter normal investors.

"Mr. Chen."

Zhang Yuyun noticed Chen Yiyang was quite troubled.

Afraid that he might not invest, she quickly continued, "We’ve completed all the preliminary work, including theoretical validation and small-scale production of finished products. Now we’re just missing the clinical trials."

"I understand," Chen Yiyang nodded.

He wasn’t considering whether to invest but how to invest.

Although only clinical trials remain,

it’s estimated that these trials will take another two to three years. The expenses during this period are the main concern, including approval fees, testing facility costs, allowances for test personnel, and follow-up inspection costs.

None of these are insignificant.

No wonder large companies in Europe and America like to conduct clinical trials on homeless people or in places like India and Africa.

The cost pressures are huge.

"I’m willing to invest the money and cover all subsequent expenses."

Chen Yiyang directly said, "But I want to acquire 100% of your company and only give you 10% of the dividend shares in the future. Can you accept that?"

"I can." Without a second thought, Zhang Yuyun agreed to Chen Yiyang’s terms.

"Ah." Chen Yiyang was a bit surprised.

His investment conditions were quite demanding.

If the artificial blood really succeeds in the future, Zhang Yuyun will barely see any of the subsequent income.

Moreover, given that New Snow Company currently lacks funds and investment prospects, the acquisition offer won’t be too high.

Yet, even with these conditions, Zhang Yuyun agreed without any hesitation.

Seeing Chen Yiyang’s surprise, Zhang Yuyun contemplated for a moment before slowly explaining why she agreed so readily.

"Mr. Chen, it’s not that I don’t care about money. But no matter how bright the future income prospects of artificial blood are, it has to pass clinical trials first.

The costs of a Phase III clinical trial are so high that even if I sold my house and took out loans, I couldn’t afford it. If this succeeds in the future, the reputation I gain will be far more valuable than some money."